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Abstract
Background: Improving the quality of health care requires a range of evidence-based activities.
Audit and feedback is commonly used as a quality improvement tool in the UK National Health
Service [NHS]. We set out to assess whether current guidance and systematic review evidence can
sufficiently inform practical decisions about how to use audit and feedback to improve quality of
care.
Methods: We selected an important chronic disease encountered in primary care: diabetes
mellitus. We identified recommendations from National Institute for Clinical Excellence (NICE)
guidance on conducting audit and generated questions which would be relevant to any attempt to
operationalise audit and feedback in a healthcare service setting. We explored the extent to which
a systematic review of audit and feedback could provide practical guidance about whether audit and
feedback should be used to improve quality of diabetes care and, if so, how audit and feedback
could be optimised.
Results: National guidance suggests the importance of securing the right organisational conditions
and processes. Review evidence suggests that audit and feedback can be effective in changing
healthcare professional practice. However, the available evidence says relatively little about the
detail of how to use audit and feedback most efficiently.
Conclusion:  Audit and feedback will continue to be an unreliable approach to quality
improvement until we learn how and when it works best. Conceptualising audit and feedback
within a theoretical framework offers a way forward.
Background
A range of strategies exist to promote the uptake of clinical
research findings into the routine care of patients. They
seek to change the behaviour of healthcare professionals
and thereby improve the quality of patient care (Table 1).
For each of these strategies a number of trials of their effec-
tiveness have been drawn together within systematic
reviews.[1,2] By examining interventions in a range of
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settings and circumstances such reviews aim to produce
generalisable messages about the effectiveness or other-
wise of these interventions.
All healthcare systems are concerned with improving the
quality of care that they deliver as demonstrated by their
establishment of structures (such as the UK NHS National
Institute for Clinical Excellence (NICE], the Australian
National Institute for Clinical Studies) and high profile
reports.[3] Across countries clinical audit (hereafter
referred to as audit and feedback) is commonly used to
both monitor and improve quality of care. [4,5]
The strategies in Table 1 vary considerably in their
resource requirements and cost effectiveness and any
healthcare system will have finite resources to commit to
quality improvement activities. Therefore to make the best
use of health service resources, interventions to change
professional behaviour should be evidence-based,
selected on the basis of their known effectiveness and effi-
ciency, and should be directed towards important clinical
conditions.
While rising prevalence and changing patterns of service
delivery diabetes mellitus increasingly contributes to the
primary care workload [6] and there is evidence of frag-
mented and variable provision of care.[7] This paper
explores the utility of current systematic review evidence
to support healthcare system decisions about how to pro-
vide evidence based audit and feedback to improve the
quality of care by considering it in the context of a com-
mon chronic condition and setting – diabetes mellitus in
primary care. We aimed to find out whether we could
operationalise audit and feedback from existing review
data.
Methods
Topic selection
The UK NHS has produced a framework and set of meas-
urable criteria by which to judge the quality of care for
patients with diabetes mellitus. The National Service
Framework (NSF) for Diabetes was launched in 2002.[8]
It suggests performance targets for primary care organisa-
tions, responsible for the commissioning and provision of
health care for defined populations. Some of these targets
have been incorporated into the revised contract for UK
primary care doctors (GPs) reflecting disease monitoring
(e.g. HbA1c measurement) or secondary prevention (e.g.
proportion of patients with HbA1c under 7.5%).[9]
Therefore, diabetes represents an appropriate condition
with which to explore the utility of audit: it is a common
condition with important consequences, effective inter-
ventions are available, measurable outcomes have been
defined, and there is potential for improvement in the
quality of care.
How best to conduct audit and feedback?
We informed the study with two definitions of audit and
feedback (Table 2). The systematic review [5] offers a nar-
rower definition than the National Institute for Clinical
Excellence, Principles for Best Practice in Clinical Audit [4]
which offers a broader definition and stresses the impor-
tance of integrating audit within an overall quality
improvement framework. The latter sets out practical con-
siderations for five stages of the audit and feedback proc-
ess: preparing for audit, selecting criteria, measuring
performance, making improvements, and sustaining
improvement (Table 3). Much emphasis is given to creat-
ing the right organisational structures and culture for suc-
cess, as well as taking account of local knowledge,
experience and skills. Both are relevant to quality
improvement at an organisational as well as individual
level. However, neither describes in detail the manner in
which audit and feedback should be conducted.
Table 1: Examples of interventions to promote professional behaviour change.
Educational outreach visits A personal visit by a trained person to a health care provider in his or her own setting
Reminders (manual or computerised] Prompts performance of a patient specific clinical action
Interactive educational meetings Participation of health care providers in workshops that include discussion or practice
Audit and feedback Any summary of clinical performance over a specified period of time
Local opinion leaders Health professionals nominated by their colleagues as being educationally influential
Local consensus process Inclusion of professionals in discussions to agreed the approach to managing a clinical problem that they have 
selected as important
Patient mediated interventions Specific information sought from or given to patients
Educational materials Distribution of recommendations for clinical care (such as clinical practice guidelines, audio-visual materials, 
electronic publications).
Didactic educational meetings Lectures with minimal participant interaction
Financial incentives payments directly rewarding health care providers for specified behaviours
Multifaceted interventions A combination of two or more interventionsBMC Health Services Research 2005, 5:50 http://www.biomedcentral.com/1472-6963/5/50
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Table 2: Definitions of audit
Definition of audit endorsed by the National Institute for Clinical Excellence [4]
A quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criteria and the 
implementation of change. Aspects of the structure, processes, and outcomes of care are selected and systematically evaluated against explicit 
criteria. Where indicated, changes are implemented at an individual, team, or service level and further monitoring is used to confirm improvement 
in healthcare delivery.
Definition of audit used by the Cochrane systematic review [5]
The provision of any summary of clinical performance over a specified period of time. The summary may include data on processes of care (e.g. 
number of diagnostic tests ordered), clinical endpoints (e.g. blood pressure readings), and clinical practice recommendations (proportion of patients 
managed in line with a recommendation).
Table 3: Guiding principles for clinical audit.[4]
Stage Recommendations Addressed within Cochrane Review?
Preparing for audit Securing stake-holder interest and involvement (e.g. professionals, 
patients or carers)
No
Selection of appropriate topic, according to whether:
• Topic concerned is of high cost, volume, or risk to staff or users No
• Evidence of a serious quality problem Yes: effects greater if low baseline
• Good evidence available to inform quality standards No
• Amenability of problem to change No
• Potential for involvement in a national audit project No
• Topic is pertinent to national policy initiatives No
• Topic is a priority for the organisation No
Clear definition of purpose of audit, e.g. to improve or ensure the 
quality of care
No
Provision of necessary support structures, i.e.
• Structured audit programme (committee structure, feedback 
mechanisms, and regular audit meetings)
No
• Sufficient funding (audit staff, time of clinical staff, data collection, 
feedback)
No
Identification of skills and people needed to carry out the audit No
Selecting criteria Definition of criteria (structure, process and outcome) No
Validity and potential to lead to improvements in care
• Evidence based No
• Related to important aspects of care No
• Measurable Yes (implicitly)
Measuring level of performance Planning data collection
• Definition of user group (and exceptions) Can't tell
• Definition of healthcare professionals involved Yes (implicitly)
• Definition of time period over which criteria apply Yes (implicitly)
Making improvements Identification of barriers to change No
Implementing change
• Establishing the right environment (at individual, team and 
organisational levels)
No
• Considering external relationships (e.g. with patients or other 
agencies)
No
• Use of other supporting interventions (e.g. educational outreach, 
reminders) and / or multifaceted interventions
Yes: not supported by evidence
Sustaining improvement Monitoring and evaluating changes, e.g. continuing audit cycle, use of 
performance indicators
No
• Appropriate organisational development (e.g. cultural change, 
adequate training)
No
• Use of existing strategic, organisational or clinical frameworks No
• Leadership NoBMC Health Services Research 2005, 5:50 http://www.biomedcentral.com/1472-6963/5/50
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We explored the extent to which a systematic review of
audit and feedback could provide practical guidance
about whether audit and feedback should be used to
improve quality of diabetes care and, if so, how audit and
feedback could be optimised. Based upon discussions
with those responsible for conducting audit and feedback
at a local level as well as our own experiences of doing so,
we identified several questions which would be relevant
to any attempt to operationalise audit and feedback in a
healthcare service setting.
• Does audit and feedback work for this condition and set-
ting, specifically improving the care of patients with a
chronic disease – diabetes mellitus – in primary care?
• Does it work equally across all dimensions of care –
from simple recording of cardiovascular risk factors to
more complex areas of care such as glycaemic control? The
latter requires a greater number of actions to achieve
which include measuring blood glucose levels, reviewing
the patient, checking compliance with drug and dietary
therapies and checking patients' understanding of the
condition.
• How should it be prepared? Should data be comparative
and if so, what should the comparator group be? Should
data be anonymised?
• How intensive should feedback be? Intuitively, provid-
ing more and personalised feedback on a recurrent and
regular basis should have a greater impact on practice than
a one-off report of (say) PCT-level aggregated data. How-
ever, it is uncertain whether the extra time and costs of
ongoing data collection and preparing more frequent
feedback would be matched by additional benefits.
• How should it be delivered – by post or by a messenger
in person? And if by a messenger who should this be?
Professionals might be more convinced by a message
delivered by a colleague with a recognised interest in dia-
betes care rather than a non-clinical facilitator.
• What activities, if any, should accompany feedback? The
likely costs and possible benefits of (say) educational
meetings or outreach visits need to be weighed up against
providing feedback via paper or computerised formats
alone.
• What should be done about the poorest performers
detected by the audit? Targeting such practices may help
close the gap between the poorest and best performers.
Alternatively, spreading effort to improve quality more
equally amongst all practices may improve average per-
formance for the whole PCT.
Results
The evidence from the systematic review
We identified a systematic review of audit and feedback
that identified and appraised 85 randomised trial.[5]
Audit and feedback was used for a wide range of clinical
topics and problems. The review conclusions were:
• audit and feedback can improve professional practice,
although the effects are generally small to moderate
• effectiveness varies substantially among different studies
• variation may be related to different methods of provid-
ing feedback or contextual factors, such as targeted behav-
iours and professionals
The review identified only five direct (head-to-head) com-
parisons of different methods of providing feedback
(Table 4). One comparison suggested that feedback by a
peer was more effective than that by a neutral observer
[10]; another that feedback from a peer physician was no
more effective than that from a nurse.[11] The other three
comparisons found no effects related to recipients (group
or individual) or content of feedback. None of these stud-
ies reported an economic evaluation.
The review also evaluated 14 direct comparisons of audit
and feedback alone compared to audit and feedback com-
bined with other interventions (multifaceted interven-
tions). There was no evidence that multifaceted
interventions worked better than audit and feedback
alone. A multivariate analysis explored potential causes of
heterogeneity in the results (study quality, whether audit
and feedback was combined with other interventions,
intensity of feedback, complexity of the targeted behav-
iour, and level of baseline compliance). Only low baseline
compliance was associated with greater effect sizes for
multifaceted interventions. There was no evidence of
larger effects with increasing intensity of feedback.
The evidence for chronic disease management
Fifteen studies relate to chronic disease management
(hypertension, diabetes, cholesterol control, depression,
asthma and end-stage renal failure). Just over half of com-
parisons indicated that audit and feedback was more
effective than doing nothing (Table 4). Using multifaceted
interventions or modifying feedback methods did not
enhance effectiveness.
The evidence for diabetes care
Four studies evaluated audit and feedback in diabetes
care, three set in primary care. Two comparisons
addressed one of our key questions (Does audit and feed-
back work for this condition and setting?) and showed
that audit and feedback, with or without other interven-BMC Health Services Research 2005, 5:50 http://www.biomedcentral.com/1472-6963/5/50
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Table 4: Evidence for questions addressed by the Cochrane Review.
Questions Most relevant analyses from 
Cochrane Review
Evidence from all trials reviewed 
(n = 85)
Evidence from chronic 
disease management 
trials (n = 15)
Evidence from trials of 
diabetes care (n = 4)
Does audit and feedback 
work?
Any intervention involving audit 
and feedback versus no 
intervention +/- educational 
materials
83 comparisons: for dichotomous 
outcomes, median adjusted relative risk 
(RR) of non-compliance was 0.85 
[Interquartile range (IQR) 0.74 to 0.96]*
Small to moderate effects 
in 11 of 19 comparisons
Moderate to large effects 
in two comparisons 
[12;13]
Audit and feedback versus other 
interventions
Five comparisons: two show audit and 
feedback more effective than reminders; 
one that local opinion leaders more 
effective; one no effect over patient 
education; one no effect of audit and 
feedback with educational meetings 
over educational meetings alone
Small effect of audit and 
feedback over reminders 
from one comparison
None
Does it work equally across 
all dimensions of care?
No direct comparisons; 
exploration of heterogeneity
No heterogeneity explained by 
complexity of the targeted behaviour
None None
How should it be prepared? 
Should data be comparative 
and if so, what should the 
comparator group be? 
Should data be anonymised?
Content. Patient information, such 
as blood pressure or test results, 
compliance with a standard or 
guideline, or peer comparison; 
versus information about costs or 
numbers of tests ordered or 
prescriptions
Two comparisons: no difference 
between peer comparison and individual 
feedback without peer comparison; nor 
between feedback on medication and 
feedback on performance
No difference between 
feedback on medication 
versus feedback on 
performance in one 
comparison
None
How intensive should 
feedback be?
Recipients. Individual or group No difference between individual versus 
group feedback in one comparison
None None
Frequency. Once only or more 
frequent feedback
None None None
Length. Once only feedback versus 
audit and feedback over a period of 
time
None None None
Short term effects compared to 
longer term effects after audit and 
feedback stops
Mixed results from 11 comparisons No difference from one 
comparison [14]
No difference from one 
comparison [14]
Exploration of heterogeneity No heterogeneity explained by intensity 
of audit and feedback
Questions Most relevant analyses from 
Cochrane Review
Evidence from all trials reviewed 
(n = 85)
Evidence from chronic 
disease management 
trials (n = 15)
Evidence from trials of 
diabetes care (n = 4)
How should it be delivered 
– by post or by a messenger 
in person? And if by a 
messenger who should this 
be?
Format. Verbal, written or both None None None
Source. Influential source [seen to 
be credible and trustworthy by the 
professional] or feedback from any 
other source
Two comparisons: peer feedback better 
than non-physician observer feedback; 
no difference between peer physician 
versus nurse feedback
No difference between 
peer physician versus 
nurse feedback in one 
comparison [11]
No difference between 
peer physician versus 
nurse feedback in one 
comparison [11]
What activities, if any, 
should accompany 
feedback?
Audit and feedback with 
complementary interventions 
versus audit and feedback alone
No clear effect of complementary 
interventions from 14 studies including 
various comparisons except for small 
effect of audit and feedback combined 
with educational outreach. Lower 
baseline compliance associated with 
larger effect sizes.
Small or mixed effects in 
two out of four 
comparisons
Outreach by peer or nurse 
more effective than 
feedback alone [11]
What should be done about 
the poorest performers 
detected by the audit?
None None None None
*Relative risk [RR] is given for non-compliance. Therefore a lower RR is equivalent to greater effect size.BMC Health Services Research 2005, 5:50 http://www.biomedcentral.com/1472-6963/5/50
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tions, was more effective than doing nothing.[12,13] A
UK primary care study.[12] showed that a multifaceted
intervention incorporating low intensity audit and feed-
back moderately improved practice, specifically recording
of key variables (e.g. glycaemic control, smoking habit).
Audit and feedback also moderately increased US primary
care physician compliance with guidelines.[13]
Two studies partially addressed three of our key questions
about how to conduct audit and feedback (How intensive
should feedback be? What activities, if any, should accom-
pany feedback? How should feedback be delivered?). In
US secondary care, there was no difference between con-
tinuing feedback against withdrawal of feedback in the
accuracy of capillary blood glucose monitoring.[14] An
Australian study of GPs found a small benefit of feedback
given by a doctor or nurse compared with feedback alone,
although it is difficult to judge whether the benefits of this
approach outweighed the additional costs.[11] There was
no difference in effect size between doctor and nurse feed-
back in this comparison. There was no relationship
between study effect size and feedback intensity, co-inter-
vention use or complexity of targeted behaviour across the
four studies.
Discussion
The review evidence was of limited use in informing the
operationalisation of evidence based audit and feedback.
A number of issues contributed to this – the heterogeneity
of the studies in the overall review, the problems of inter-
preting sub-groups of studies within the larger review, and
the lack of direct evidence (particularly from head-to-head
comparisons) to answer key questions.
It is unclear how to use the review to extract generalisable
lessons about how audit and feedback achieves its effects.
For example, individual level feedback could reasonably
be assumed to be more personally relevant and persuasive
and thus more effective than feedback at a group level;
there are no such direct comparisons available. Four out
of 10 studies using individual feedback for chronic disease
management reported no effect whilst both studies using
group feedback reported positive effects. Therefore group
feedback might be more effective than individual feed-
back, possibly by promoting peer pressure, consensus and
subsequent action. Unfortunately this must all remain
conjecture given the paucity of data to test different
hypotheses about the causal mechanisms that make audit
and feedback work.
Based upon a limited number of comparisons, audit and
feedback appears to work better for diabetes than for
other conditions. It is unclear whether this is because
there is something intrinsically different about diabetes
(or the audit methods used in diabetes) compared to
other conditions, or whether this is an unreliable sub-
group analysis of four studies selected from the 85 availa-
ble. It is hard to have confidence in the findings of the dia-
betes studies in the absence of good, preferably a priori,
reasons as to why these studies should be examined sepa-
rately from others in the review.
Similar pitfalls exist in judging the relative effectiveness of
different feedback methods. This is mainly because of the
limited number of head-to-head comparisons comparing
audit and feedback alone against combined interventions
or variations in providing feedback. Across all studies,
audit and feedback alone appears similarly effective to
multifaceted strategies. However, the lack of difference in
effect size could have occurred because multifaceted strat-
egies were used in situations where investigators judged
them necessary to overcome greater obstacles to improv-
ing care. In the absence of primary studies, the review can-
not address some of the key questions such as whether
intensive feedback would improve more complex out-
comes (gylcaemic control) at an acceptable cost.
Mapped back onto the principles for good clinical audit,
the evidence only supports doing audit if there is low
baseline compliance (Table 3). This evidence relates to sit-
uations where there is low mean baseline compliance
across all study physicians rather than relating solely to a
selected “low compliance” group. Thus it is of no direct
relevance to the key question of whether or not audit and
feedback can promote change in poorly performing indi-
viduals. However, a baseline audit of multiple aspects of
diabetes care would enable targeting of implementation
activities at areas of low compliance.
The issues of external validity of randomised controlled
trials (and by inference, systematic reviews) have been
aired in the context of clinical studies.[15,16]. However,
what we have had to deal with here is more to do with
inadequate description of the interventions in the primary
studies and an inadequate understanding of the causal
mechanisms by which the intervention or its variants
might exert their effects. Thus this lack of fundamental
understanding accounts for the impossibility of assessing
a behaviour change interventions' applicability to a partic-
ular service setting. We are a long way from being able to
do what is now commonplace with clinical studies in
terms of assessing the applicability of a clinical study to an
individual patient.[17]
A rational approach to this situation is to develop a con-
ceptual framework within which to describe common ele-
ments of settings, individuals, targeted behaviours and
interventions [18-20]. This would enable the identifica-
tion of features that systematically influence the effective-
ness of interventions. For example, the effectiveness ofBMC Health Services Research 2005, 5:50 http://www.biomedcentral.com/1472-6963/5/50
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audit and feedback may be influenced by factors such as
health professionals' motivation to change or perceived
peer pressure – generalisable concepts that can be used
across different contexts. Behavioural theory can identify
potentially modifiable factors underlying professional
behaviour in order to identify those processes to target
with an intervention. Hence, if perceived peer pressure
was predictive of adherence to good practice criteria, feed-
back incorporating peer comparison might enhance effec-
tiveness. This approach potentially offers a method for
more effective selection and development of interventions
to improve practice. The longer term possibility is to
establish a theoretically grounded basis for selecting or
tailoring interventions given specific barriers and circum-
stances. This would apply to all behaviour change strate-
gies, not just audit and feedback.
Conclusion
Review evidence was of limited use in informing the oper-
ationalisation of evidence based audit and feedback. This
is mainly because of the heterogeneity of the studies in the
overall review, the problems of interpreting sub-groups of
studies within the larger review, and the lack of head-to-
head comparisons to answer key questions. Audit and
feedback will continue to be an unreliable approach to
quality improvement until we learn how and when it
works best. Conceptualising audit and feedback within a
theoretical framework offers a way forward.
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